AptarGroup Gains After 4Q Results, Buyback Plan

Dow Jones02-07 02:32

By Josh Beckerman

Shares of AptarGroup rose after the company reported fourth-quarter results and announced a $600 million buyback authorization.

The stock was recently up 7.3%, to $133.02, but has fallen about 7% over the past 52 weeks.

AptarGroup, which provides dosing, dispensing and protection technologies for drugs and consumer products, said sales rose 14%, to $962.7 million. The prescription division benefited from strong demand for systemic nasal drug delivery used for central nervous system therapies and pain management, while the injectables division was helped by growth in GLP-1 elastomeric components.

Adjusted earnings per share fell to $1.25 from $1.62. In October, the company said, in the short term, it expected to face tough comparisons from a one-time naloxone ramp-up and said it expected fourth-quarter adjusted earnings of $1.20 to $1.28 a share. AptarGroup said Thursday that it expects $1.13 to $1.21 for the first quarter.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

February 06, 2026 13:32 ET (18:32 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2609638515?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-07 02:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609638515","market":"other","top_or_hot":-1,"title":"AptarGroup Gains After 4Q Results, Buyback Plan","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Josh Beckerman \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of AptarGroup rose after the company reported fourth-quarter results and announced a $600 million buyback authorization. \n</p>\n<p>\n  The stock was recently up 7.3%, to $133.02, but has fallen about 7% over the past 52 weeks. \n</p>\n<p>\n  AptarGroup, which provides dosing, dispensing and protection technologies for drugs and consumer products, said sales rose 14%, to $962.7 million. The prescription division benefited from strong demand for systemic nasal drug delivery used for central nervous system therapies and pain management, while the injectables division was helped by growth in GLP-1 elastomeric components. \n</p>\n<p>\n  Adjusted earnings per share fell to $1.25 from $1.62. In October, the company said, in the short term, it expected to face tough comparisons from a one-time naloxone ramp-up and said it expected fourth-quarter adjusted earnings of $1.20 to $1.28 a share. AptarGroup said Thursday that it expects $1.13 to $1.21 for the first quarter. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 06, 2026 13:32 ET (18:32 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AptarGroup Gains After 4Q Results, Buyback Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAptarGroup Gains After 4Q Results, Buyback Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-07 02:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Josh Beckerman \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of AptarGroup rose after the company reported fourth-quarter results and announced a $600 million buyback authorization. \n</p>\n<p>\n  The stock was recently up 7.3%, to $133.02, but has fallen about 7% over the past 52 weeks. \n</p>\n<p>\n  AptarGroup, which provides dosing, dispensing and protection technologies for drugs and consumer products, said sales rose 14%, to $962.7 million. The prescription division benefited from strong demand for systemic nasal drug delivery used for central nervous system therapies and pain management, while the injectables division was helped by growth in GLP-1 elastomeric components. \n</p>\n<p>\n  Adjusted earnings per share fell to $1.25 from $1.62. In October, the company said, in the short term, it expected to face tough comparisons from a one-time naloxone ramp-up and said it expected fourth-quarter adjusted earnings of $1.20 to $1.28 a share. AptarGroup said Thursday that it expects $1.13 to $1.21 for the first quarter. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 06, 2026 13:32 ET (18:32 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATR","symbol_name":"Aptar","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2609638515","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609638515","pubTimestamp":1770402720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of AptarGroup rose after the company reported fourth-quarter results and announced a $600 million buyback authorization.The stock was recently up 7.3%, to $133.02, but has fallen about 7% over the past 52 weeks.AptarGroup, which provides dosing, dispensing and protection technologies for drugs and consumer products, said sales rose 14%, to $962.7 million. The prescription division benefited from strong demand for systemic nasal drug delivery used for central nervous system therapies and pain management, while the injectables division was helped by growth in GLP-1 elastomeric components.Adjusted earnings per share fell to $1.25 from $1.62. In October, the company said, in the short term, it expected to face tough comparisons from a one-time naloxone ramp-up and said it expected fourth-quarter adjusted earnings of $1.20 to $1.28 a share. AptarGroup said Thursday that it expects $1.13 to $1.21 for the first quarter.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATR":"Aptar","BK4126":"金属与玻璃容器"},"translate_title":"AptarGroup在第四季度业绩和回购计划后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATR":1.5},"content_text":"By Josh Beckerman \n\n\n \n\n\n  Shares of AptarGroup rose after the company reported fourth-quarter results and announced a $600 million buyback authorization. \n\n\n  The stock was recently up 7.3%, to $133.02, but has fallen about 7% over the past 52 weeks. \n\n\n  AptarGroup, which provides dosing, dispensing and protection technologies for drugs and consumer products, said sales rose 14%, to $962.7 million. The prescription division benefited from strong demand for systemic nasal drug delivery used for central nervous system therapies and pain management, while the injectables division was helped by growth in GLP-1 elastomeric components. \n\n\n  Adjusted earnings per share fell to $1.25 from $1.62. In October, the company said, in the short term, it expected to face tough comparisons from a one-time naloxone ramp-up and said it expected fourth-quarter adjusted earnings of $1.20 to $1.28 a share. AptarGroup said Thursday that it expects $1.13 to $1.21 for the first quarter. \n\n\n \n\n\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 06, 2026 13:32 ET (18:32 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609638515","isCrawlerRequest":true}